Induces potent and long-lasting immune responses to defined antigens or whole pathogens (particles), mainly through the ...

In a new study, researchers have determined that a protein called NF-kB c-Rel can intensify the symptoms of psoriasis when activated by signals from the body's immune system. Understanding how 'c-Rel' ...

A recent study carried out by a research team from the Paul-Ehrlich-Institut investigated the immunomodulating properties of ...

known as conventional type 1 dendritic cells (cDC1s). These cells, located in parts of the gut like the ileum, can activate ...

A research team has investigated a new combination therapy against cancer. This therapy employs systemic administration of the tissue hormone interferon-I combined with local application of Imiquimod.

Finding offers potential new target for treatmentPsoriasis, a painful and uncomfortable inflammatory skin condition that ...

This work could advance the understanding of immune system responses and pave the way for improved vaccines and immunotherapies ...

The results indicate that β-glucans can target the immune system and modulate pro-inflammatory responses. Their potential to suppress allergic reactions and offer new approaches to allergy treatment ...

Researchers at MedUni Vienna have developed a combination therapy using systemic interferon-I and topical imiquimod.

Effective for local tumors and distant metastases Immunotherapies use the body's own immune system to fight cancer cells. Plasmacytoid dendritic cells (pDCs), which are activated by Imiquimod via ...

Effective for local tumors and distant metastases Immunotherapies use the body's own immune system to fight cancer cells. Plasmacytoid dendritic cells (pDCs), which are activated by Imiquimod via ...

But T cells do not work alone; they rely on activation from other immune cells, particularly antigen-presenting cells (APCs) such as dendritic cells—the main T cell activators.